Presentations, analyst reports,
documents & videos

Corporate presentations

Latest Corporate Presentation Corporate Presentation January 2021

Analyst reports

Documents

Videos and webcasts

07-Dec-2020
CEO Lisa Anson discussed £25.5m raise to drive forward key programmes

10-Jun-2020
Chief Medical Officer, Dr Andrew Saunders, provides updates on lead oncology asset RXC004

Latest

09-Jun-2020 Chief Scientific Officer Richard Armer provides updates on lead fibrosis asset RXC007 which has potential for development in multiple fibrotic conditions